ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes
- PMID: 38676722
- DOI: 10.1007/s00125-024-06156-x
ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes
Abstract
Aims: Lactate accumulation is reported to be a biomarker for diabetic nephropathy progression. Lactate drives lysine lactylation, a newly discovered post-translational modification that is involved in the pathogenesis of cancers and metabolic and inflammatory disease. Here, we aimed to determine whether lysine lactylation is involved in the pathogenesis of diabetic nephropathy.
Methods: Renal biopsy samples from individuals with diabetic nephropathy (n=22) and control samples from individuals without diabetes and kidney disease (n=9) were obtained from the First Affiliated Hospital of Zhengzhou University for immunohistochemical staining. In addition, we carried out global lactylome profiling of kidney tissues from db/m and db/db mice using LC-MS/MS. Furthermore, we assessed the role of lysine lactylation and acyl-CoA synthetase family member 2 (ACSF2) in mitochondrial function in human proximal tubular epithelial cells (HK-2).
Results: The expression level of lysine lactylation was significantly increased in the kidneys of individuals with diabetes as well as in kidneys from db/db mice. Integrative lactylome analysis of the kidneys of db/db and db/m mice identified 165 upregulated proteins and 17 downregulated proteins, with an increase in 356 lysine lactylation sites and a decrease in 22 lysine lactylation sites decreased. Subcellular localisation analysis revealed that most lactylated proteins were found in the mitochondria (115 proteins, 269 sites). We further found that lactylation of the K182 site in ACSF2 contributes to mitochondrial dysfunction. Finally, the expression of ACSF2 was notably increased in the kidneys of db/db mice and individuals with diabetic nephropathy.
Conclusions: Our study strongly suggests that lysine lactylation and ACSF2 are mediators of mitochondrial dysfunction and may contribute to the progression of diabetic nephropathy.
Data availability: The LC-MS/MS proteomics data have been deposited in the ProteomeXchange Consortium database ( https://proteomecentral.proteomexchange.org ) via the iProX partner repository with the dataset identifier PXD050070.
Keywords: ACSF2; Diabetic nephropathy; LC-MS/MS; Lysine lactylation; Mitochondrial dysfunction.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Umanath K, Lewis JB (2018) Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis 71(6):884–895. https://doi.org/10.1053/j.ajkd.2017.10.026 - DOI - PubMed
-
- Cheng HT, Xu X, Lim PS, Hung KY (2021) Worldwide epidemiology of diabetes-related end-stage renal disease, 2000–2015. Diabetes Care 44(1):89–97. https://doi.org/10.2337/dc20-1913 - DOI - PubMed
-
- Fioretto P, Pontremoli R (2022) Expanding the therapy options for diabetic kidney disease. Nat Rev Nephrol 18(2):78–79. https://doi.org/10.1038/s41581-021-00522-3 - DOI - PubMed
-
- Lee DY, Kim JY, Ahn E et al (2022) Associations between local acidosis induced by renal LDHA and renal fibrosis and mitochondrial abnormalities in patients with diabetic kidney disease. Transl Res 249:88–109. https://doi.org/10.1016/j.trsl.2022.06.015 - DOI - PubMed
-
- Kugathasan L, Darshi M, Srinivasan Sridhar V et al (2023) 12-OR: Urine lactate is a disease biomarker for diabetic kidney disease. Diabetes 72(Supplement_1):12-OR. https://doi.org/10.2337/db23-12-OR - DOI
MeSH terms
Substances
Grants and funding
- No.202300410363/Natural Science Foundation of Henan Province Excellent Young Scientists Fund Program
- No.81970633/National Natural Science Foundation of China General Project
- No.82200796/National Natural Science Foundation of China Young Scientists Project
- SBGJ202102145/the Medical Science and Technology Research Project of Henan Province
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous